Previous close | 15.26 |
Open | 15.91 |
Bid | 11.27 x 200 |
Ask | 19.91 x 200 |
Day's range | 15.54 - 15.91 |
52-week range | 9.22 - 17.96 |
Volume | |
Avg. volume | 9,327 |
Net assets | 13.98M |
NAV | 15.70 |
PE ratio (TTM) | N/A |
Yield | 0.00% |
YTD daily total return | 17.45% |
Beta (5Y monthly) | 0.88 |
Expense ratio (net) | 0.79% |
Inception date | 2015-10-13 |
Exchange Traded Concepts, LLC, adviser to the Range Cancer Therapeutics ETF (CNCR) and the Loncar China BioPharma ETF (CHNA) is pleased to announce the completion of the reorganization of CHNA into CNCR following the close of business on October 20, 2023.